What is the appropriate management of flecainide toxicity?

Management of Flecainide Toxicity

Administer intravenous sodium bicarbonate immediately for flecainide toxicity, particularly when QRS prolongation or ventricular arrhythmias are present. This is the primary, evidence-based treatment for sodium channel blocker toxicity including flecainide.

Initial Assessment and Recognition

Flecainide toxicity presents with characteristic ECG findings and cardiovascular collapse:

• QRS widening (often >25% from baseline, can reach 150% increase)
• Bradycardia and conduction delays (first-degree AV block in ~33% of patients, second- or third-degree block possible)
• Ventricular arrhythmias including wide-complex tachycardia, ventricular tachycardia, and ventricular fibrillation
• Hypotension and cardiogenic shock due to negative inotropic effects
• CNS manifestations (altered mental status, visual hallucinations, encephalopathy in severe cases)

Check for precipitating factors: renal impairment (flecainide is renally cleared), drug interactions (especially amiodarone), or intentional/accidental overdose 1, 2, 3.

Primary Treatment: Sodium Bicarbonate

Give 1-2 mEq/kg (1-2 mL/kg of 8.4% solution) intravenous boluses of sodium bicarbonate until arterial pH reaches >7.45-7.50 4, 5. This is a Class 2a recommendation with Level C-LD evidence for sodium channel blocker toxicity 4.

• Mechanism: Sodium loading and alkalinization reverse sodium channel blockade
• Repeat boluses every 5 minutes as needed for persistent QRS widening or arrhythmias
• Follow with continuous infusion: 150 mEq NaHCO₃ per liter of D5W to maintain alkalosis 6, 4
• Monitor: Serial ECGs for QRS narrowing, arterial blood gases for pH, serum sodium to avoid extreme hypernatremia

Multiple case reports demonstrate rapid QRS normalization and rhythm conversion within 12 hours of sodium bicarbonate therapy 1, 2, 7.

Hemodynamic Support

For hypotension refractory to sodium bicarbonate:

• First-line vasopressors: Epinephrine and norepinephrine are more effective than dopamine for sodium channel blocker toxicity 6
• Avoid: Class IA (quinidine, procainamide), Class IC (other sodium channel blockers), and Class III antiarrhythmics (amiodarone, sotalol) which may exacerbate cardiac toxicity 6, 8

Advanced Therapies for Refractory Cases

Intravenous Lipid Emulsion (ILE)

Consider 20% lipid emulsion for severe, refractory flecainide toxicity 4, 9, 10:

• Dosing: 1.5 mL/kg bolus over 1 minute, followed by 0.25 mL/kg/min infusion for 30-60 minutes
• Evidence: Class 2b recommendation (may be reasonable) for local anesthetic systemic toxicity; case reports show efficacy in flecainide overdose 4, 9, 10
• Mechanism: Lipid sink effect, enhanced cardiac contractility

Extracorporeal Membrane Oxygenation (ECMO)

ECMO may be considered for cardiac arrest or refractory shock despite high-dose vasopressors and sodium bicarbonate 4, 10:

• Class 2b recommendation for sodium channel blocker toxicity 4
• Provides circulatory support while drug is eliminated (flecainide half-life: 12-27 hours in normal renal function, prolonged in renal impairment)

Cardiac Pacing Considerations

Flecainide increases pacing thresholds significantly 11, 7:

• Temporary pacing may be ineffective due to elevated capture thresholds
• If pacing is required, double the voltage or pulse width to regain capture 11
• Pacing thresholds normalize after flecainide levels decline 7

Specific Management Pitfalls

Do NOT use:

• Other antiarrhythmic drugs (Class IA, IC, or III agents) - they worsen toxicity 6, 8
• Amiodarone - contraindicated despite being used in some older case reports; it failed to normalize QRS in documented cases 1
• Calcium channel blockers or beta-blockers for rate control - may worsen hypotension

Monitoring and Disposition

• Continuous cardiac monitoring until QRS normalizes and hemodynamics stabilize
• Serial ECGs every 1-2 hours initially
• Plasma flecainide levels if available (therapeutic: 0.2-1.0 mcg/mL; toxicity likely >1.0 mcg/mL) 11
• Renal function monitoring - adjust for clearance
• ICU admission for all cases of significant toxicity

Duration of Treatment

Continue sodium bicarbonate infusion until:

• QRS duration returns to baseline or <120 ms
• Hemodynamics stabilize
• Ventricular arrhythmias resolve
• Typically requires 12-24 hours of treatment 1, 2, 7

Key principle: Flecainide toxicity is primarily managed with sodium bicarbonate, not with additional antiarrhythmic drugs. Early recognition and aggressive alkalinization prevent cardiovascular collapse and mortality.